These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3793297)

  • 1. Antipyrine kinetics following tetanus vaccination.
    Descotes J; Simonet R; Evreux JC
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):625-6. PubMed ID: 3793297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipyrine kinetics following influenza vaccination.
    Simonet R; Descotes J; Evreux JC
    Int J Clin Pharmacol Res; 1986; 6(3):231-3. PubMed ID: 3744625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of six beta-adrenolytics and labetalol on hepatic biotransformation studied by antipyrine test, in man.
    Adamska-Dyniewska H; Dziekański S; Pruszczyński J
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):303-7. PubMed ID: 2874117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
    Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S79-88. PubMed ID: 3842695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of age on antipyrine metabolism in patients with gastric cancer.
    Higuchi T; Nakamura T; Uchino H
    J Natl Cancer Inst; 1980 Nov; 65(5):897-900. PubMed ID: 6933259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyrine kinetics in Nigerian women in chronic renal failure.
    Iyun AO; Tucker GT
    Afr J Med Med Sci; 1982 Mar; 11(1):7-9. PubMed ID: 6291357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of tetanus and typhoid vaccines on hepatic drug metabolism.
    Descotes J; Guillermin A; Evreux JC
    Pharmacology; 1988; 36(2):134-9. PubMed ID: 3353440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of hepatic drug metabolism in female patients with congestive cardiac failure.
    Rissam HS; Nair CR; Anand IS; Madappa C; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):602-4. PubMed ID: 6668098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mono-oxygenase enzyme system of the liver in patients with true eczema].
    Ashirmetov AKh; Akovbian VA; Krakovskiĭ ME; Tikhonova NN
    Vestn Dermatol Venerol; 1990; (4):46-9. PubMed ID: 2143879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of several bacterial and viral vaccines on hepatic drug metabolism in mice.
    Descotes J; Simonet R; Evreux JC
    Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):481-3. PubMed ID: 4079599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of ranitidine on antipyrine metabolism (author's transl)].
    Staiger C; Simon B; de Vries J; Kather H; Walter E
    Z Gastroenterol; 1980 Dec; 18(12):601-4. PubMed ID: 6116365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The antipyrine test in occupational medicine research--evaluation of individual reproducibility and frequency distribution of half-life].
    Uhlig H; Damrau J; Skölziger R
    Z Gesamte Hyg; 1989 Feb; 35(2):82-4. PubMed ID: 2741499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketoconazole does not impair antipyrine clearance in humans.
    Blyden GT; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):225-6. PubMed ID: 3733272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
    Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT
    Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination].
    Soto Alvarez J; Alsar Ortiz MJ
    Rev Clin Esp; 1993 Jun; 193(2):60-3. PubMed ID: 8341815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.